Wegman Mark N
Director at BIOSPECIFICS TECHNOLOGIES CORP
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 5
- Latest May 24, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOSPECIFICS TECHNOLOGIES CORPDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedAug 23, 2018 2018
Sold 8,500 shares at $52.63 ($447k)
Wegman Mark N, Director
Sold 10.6% of holdings ($4.2M position)71,772 shares leftFirst sale on recordFiling
- 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 11, 2018 +19 days
Sold 6,500 shares at $57.52 ($374k)
Wegman Mark N, Director
Sold 9.1% of holdings ($4.1M position)65,272 shares leftFiling
- 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedMay 21, 2019 +252 days
Sold 6,000 shares at $64.04 ($384k)
Wegman Mark N, Director
Sold 7.5% of holdings ($5.1M position)74,272 shares leftFiling
- 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedMay 22, 2019 +1 day
Sold 1,200 shares at $63.70 ($76k)
Wegman Mark N, Director
Sold 1.6% of holdings ($4.7M position)73,072 shares left0.2x usual sizeFiling
- 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedMay 24, 2019 +2 days
Sold 7,800 shares at $61.09 ($477k)
Wegman Mark N, Director
Sold 10.7% of holdings ($4.5M position)65,272 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2019 | May 28, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 7,800 | $477k | 10.7% | Plan not stated | SEC |
| May 22, 2019 | May 23, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 1,200 | $76k | 1.6% | Plan not stated | SEC |
| May 21, 2019 | May 22, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 6,000 | $384k | 7.5% | Plan not stated | SEC |
| Sep 11, 2018 | Sep 11, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 6,500 | $374k | 9.1% | Plan not stated | SEC |
| Aug 23, 2018 | Aug 23, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 8,500 | $447k | 10.6% | Plan not stated | SEC |